Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detec

› Budget101 Discussion List Archives › Recalls › Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detec

Viewing 0 reply threads
  • Author
    Posts
    • November 9, 2018 at 2:10 pm #389337
      budget

      Sandoz Inc. is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level. This product is being recalled due to the trace amount of an impurity, N-nitrosodiethylamine (ndea) contained in the api losartan, usp manufactured by zhejiang huahai pharmaceutical co.

      ltd. sandoz inc. losartan potassium hydrochlorothiazide product is manufactured by lek pharmaceuticals dd, ljubljana, slovenia.

      this impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a probable human carcinogen as per international agency for research on cancer (iarc).

      Read More…

      This notice provided by Budget101.com

  • Author
    Posts
Viewing 0 reply threads
  • You must be logged in to reply to this topic.

› Budget101 Discussion List Archives › Recalls › Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detec